Products & Services
Applications

Applications

Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.

Learn about applications
View all Applications
Resources
News Explore
Contact

New nanopore sequencing chemistry in developers’  hands; set to deliver Q20+ (99%+) “raw read” accuracy  

1st March 2021

A new nanopore sequencing kit is now being tested by a number of developers in the nanopore user community.  The kit features a modified enzyme, tweaked run conditions and a further impro...

Read more

Answered: 11 questions about presenting at London Calling 2021 (and why we’d love you to take part)

17th February 2021

Due to current COVID-19 restrictions and following on from the success of last year’s virtual London Calling conference, the upcoming London Calling 2021 is also going ahead online. Ki...

Read more

Mobile laboratories use LamPORE COVID-19 test, UK Government LamPORE evaluation report shows high accuracy

29th January 2021

Mobile COVID-19 testing laboratories containing Oxford Nanopore’s LamPORE test are now being deployed in a pilot programme, to support testing efforts, including in remote locations. The...

Read more

Oxford Nanopore and NVIDIA collaborate to partner the DGX AI compute system with ultra-high throughput PromethION sequencer

12th January 2021

Oxford Nanopore Technologies and NVIDIA are collaborating this year to integrate the NVIDIA DGX Station A100 into Oxford Nanopore’s ultra-high throughput sequencing system, PromethION. P...

Read more

20 moments we will remember from 2020

31st December 2020

Dear all, As each year draws to an end, we reflect on its highlights. You can read our 2019 and 2018 blogs here. But 2020 was a year like no other; it's hard to think of the following as...

Read more

Large study in UK NHS labs shows gold-standard accuracy of Oxford Nanopore’s COVID-19 test LamPORE for both symptomatic and asymptomatic patients

21st December 2020

Oxford, 21st December 2020. A study of more than 23,000 samples carried out by teams across the UK shows Oxford Nanopore’s COVID-19 test, LamPORE, is highly accurate for the detection of...

Read more

Oxford Nanopore and SourceBio announce commercial partnership for UK COVID-19 testing service

15th December 2020

Oxford Nanopore’s rapid LamPORE COVID-19 test to be made available via SourceBio accredited lab facilities. Oxford Nanopore Technologies Limited (“Oxford Nanopore”), a leading next gene...

Read more

At NCM, announcements include single-read accuracy of 99.1% on new chemistry and sequencing a record 10 Tb in a single PromethION run

3rd December 2020

During an update at the 2020 Nanopore Community Meeting, Oxford Nanopore revealed a number of key advances in its sequencing technology. These include the release of new improvements in ...

Read more

Two new papers further demonstrate the role adaptive sampling could play in understanding genetic disease

30th November 2020

Two new papers published in Nature Biotech today, from teams at the University of Nottingham and Johns Hopkins University, demonstrate the use of real-time nanopore sequencing and adaptiv...

Read more

Introducing the new MinKNOW App

25th November 2020

Today marks the release of the MinKNOW App for iOS and Android devices, now available to download from the Apple Store and Google Play. MinKNOW is the operating software that drives nano...

Read more

Structural variation & cancer: top 7 things to read right now

20th November 2020

Somatic mutations are the driving force behind cancer development, and structural variations (SVs) are more and more being recognised as an important class of these mutations. The detecti...

Read more

Interview: Nanopore sequencing: the mobile methylome

17th November 2020

Adam Ewing leads the Translational Bioinformatics Group at the Mater Research Institute - University of Queensland in Australia, where he works to develop methods and software for analy...

Read more

Structural variation in human genomics: 6 things to read right now

3rd November 2020

The significance of structural variation in human genomics is becoming increasingly established in many fields, from cancer to neurology and the mechanisms of rare disease. With research ...

Read more

Epigenetics, Cas9-mediated enrichment and novel insights in transcriptome variation: catch up on talks from ASHG 2020

30th October 2020

This week we heard from Ariel Gershman, Shruti Iyer and Tuuli Lappalainen on their latest research addressing some of the key challenges in human genomics using nanopore technology. The t...

Read more

Oxford Nanopore announces multiple releases, for high-accuracy, content-rich, high-throughput whole-genome sequencing, and dynamic targeted sequencing

28th October 2020

- announced at the 2020 American Society of Human Genetics (ASHG) Meeting. Oxford, UK, 28th October 2020. Oxford Nanopore announces multiple releases that expand and improve its sequen...

Read more

Your Oxford Nanopore guide to ASHG 2020 online

26th October 2020

ASHG 2020 has moved online this year but there’s still plenty going on and lots of ways you can find out about how human genomics researchers are overcoming some of the big challenges i...

Read more

Blog: cuteSV - a powerful tool to uncover the full spectrum of genomic structural variants

19th October 2020

In this blog, Tao Jiang describes his work on the development of the structural variant (SV) caller cuteSV. Read on to find out how the cuteSV bioinformatics pipeline works, how it perfor...

Read more

Oxford Nanopore announces £84.4M in new capital

13th October 2020

Oxford, UK: Oxford Nanopore Technologies has raised £84.4M in new capital. The funding comes from existing investors and new investors, including International Holdings Company (IHC), R...

Read more

Oxford Nanopore, the Bill and Melinda Gates Foundation, Africa Centres for Disease Control and Prevention and other partners collaborate to transform disease surveillance in Africa

12th October 2020

Oxford Nanopore, the Bill & Melinda Gates Foundation, US CDC, Microsoft and Illumina collaborate with the Africa Centres for Disease Control and Prevention (Africa CDC) to launch Afri...

Read more

LamPORE test for SARS-CoV-2 detection gains CE-IVD mark

9th October 2020

LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19. LamPORE is designed to be performed on a desktop device, GridION, or a pa...

Read more

Interview: Improving structural variant interpretation for hereditary cancer susceptibility

5th October 2020

Accurate molecular diagnosis of cancer-causing germline variants enables increased screening, early detection, prevention, and optimal treatment, if cancer does arise in predisposed pat...

Read more

Oxford Nanopore welcomes Dr Guy Harmelin as a non-executive Director

2nd October 2020

Guy has extensive experience in healthcare and technology investment and entrepreneurship. He was previously on the leadership team at Harel Insurance Investments and Financial Services, ...

Read more

Blog: Copy number variation analysis from plasma: is it feasible using nanopore sequencing?

29th September 2020

In this blog, Filippo Martignano shares his research into copy number variation (CNV) analysis in cancer, from cell-free DNA samples, using shallow whole-genome sequencing. Read on to hea...

Read more

LamPORE evaluation study shows 99.1% sensitivity, 99.6% specificity

25th September 2020

Scientists from the University of Oxford’s Nuffield Department of Medicine, Public Health England Porton Down (PHE), the University of Sheffield, Sheffield Teaching Hospitals NHS Foundati...

Read more
Open a chat to talk to our sales team
FAQs

FAQs

Search